Vigil Neuroscience, Inc. announced the launch of ALSPAware, a new program providing no-cost genetic testing and counseling services for the diagnosis of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP). The program is coordinated by InformedDNA®, the largest independent provider of genetic counseling services, and PreventionGenetics, an Exact Sciences Company running an accredited laboratory that delivers high-quality genetic testing. ALSPAware offers no-cost, confidential genetic testing and counseling services to U.S. residents age 18 and over.

Developed with both patients and healthcare providers in mind, the program includes a single gene confirmatory test for individuals with a family history of ALSP, as well as a custom gene panel available for physicians to use in diagnosing adult-onset neurological diseases. Trained genetic counselors are available to facilitate testing and discuss results, and participants will have access to a range of specialized information and services created to support participants and their families. By increasing access to genetic testing for both individuals and healthcare providers, they believe ALSPAware has the potential to help reduce initial misdiagnosis of this disease, while also providing appropriate disease management services for those living with ALSP.

Increased access to genetic testing has been an important goal in the ALSP community for many years. ALSPAware was developed with input from leaders from the patient advocacy community including Sisters' Hope Foundation, United Leukodystrophy Foundation and Hunter's Hope Foundation, to ensure the program addresses the key challenges patients, caregivers and healthcare providers face during the genetic testing and counseling process.